Full text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Spermatogonial stem cell (SSC) transplantation into the testis of a germ cell (GC)-depleted surrogate allows transmission of donor genotype via donor-derived sperm produced by the recipient. Transplantation of gene-edited SSCs provides an approach to propagate gene-edited large animal models. DAZL is a conserved RNA-binding protein important for GC development, and DAZL knockout (KO) causes defects in GC commitment and differentiation. We characterized DAZL-KO pigs as SSC transplantation recipients. While there were GCs in 1-week-old (wko) KO, complete GC depletion was observed by 10 wko. Donor GCs were transplanted into 18 DAZL-KO recipients at 10–13 wko. At sexual maturity, semen and testes were evaluated for transplantation efficiency and spermatogenesis. Approximately 22% of recipient seminiferous tubules contained GCs, including elongated spermatids and proliferating spermatogonia. The ejaculate of 89% of recipients contained sperm, exclusively from donor origin. However, sperm concentration was lower than the wild-type range. Testicular protein expression and serum hormonal levels were comparable between DAZL-KO and wild-type. Intratesticular testosterone and Leydig cell volume were increased, and Leydig cell number decreased in transplanted DAZL-KO testis compared to wild-type. In summary, DAZL-KO pigs support donor-derived spermatogenesis following SSC transplantation, but low spermatogenic efficiency currently limits their use for the production of offspring.

Details

Title
DAZL Knockout Pigs as Recipients for Spermatogonial Stem Cell Transplantation
Author
Lara, Nathalia L M 1   VIAFID ORCID Logo  ; Goldsmith, Taylor 2 ; Rodriguez-Villamil, Paula 2 ; Ongaratto, Felipe 2 ; Solin, Staci 2 ; Webster, Dennis 2 ; Ganbaatar, Uyanga 2 ; Hodgson, Shane 2 ; Stanislas M A S Corbière 2   VIAFID ORCID Logo  ; Bondareva, Alla 1 ; Carlson, Daniel F 2 ; Dobrinski, Ina 1   VIAFID ORCID Logo 

 Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N4N1, Canada; [email protected] (N.L.M.L.); [email protected] (A.B.) 
 Recombinetics, Inc., St. Paul, MN 55121, USA; [email protected] (T.G.); [email protected] (D.W.); [email protected] (S.H.); [email protected] (S.M.A.S.C.); [email protected] (D.F.C.) 
First page
2582
Publication year
2023
Publication date
2023
Publisher
MDPI AG
e-ISSN
20734409
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2888055476
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.